Trials / Completed
CompletedNCT00767507
Maintenance of Platelet Inhibition With Cangrelor
BRIDGE: Maintenance of Platelet inihiBition With cangRelor After dIscontinuation of ThienopyriDines in Patients Undergoing surGEry
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 221 (actual)
- Sponsor
- The Medicines Company · Industry
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to demonstrate that patients receiving cangrelor infusion before coronary artery bypass grafting have an acceptable safety profile and can undergo surgery without excessive bleeding peri-operatively.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | cangrelor | |
| OTHER | Placebo | Placebo IV infusion administered in the same fashion as the active study drug in order to maintain the blind in the study. |
Timeline
- Start date
- 2008-10-01
- Primary completion
- 2011-06-01
- Completion
- 2011-07-01
- First posted
- 2008-10-07
- Last updated
- 2014-04-04
- Results posted
- 2014-04-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00767507. Inclusion in this directory is not an endorsement.